Search Results - "Reaman, Gregory H."

Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group by HUNGER, Stephen P, XIAOMIN LU, DEVIDAS, Meenakshi, CAMITTA, Bruce M, GAYNON, Paul S, WINICK, Naomi J, REAMAN, Gregory H, CARROLL, William L

“…To examine population-based improvements in survival and the impact of clinical covariates on outcome among children and adolescents with acute lymphoblastic…”
Get full text

Declining childhood and adolescent cancer mortality by Smith, Malcolm A., Altekruse, Sean F., Adamson, Peter C., Reaman, Gregory H., Seibel, Nita L.

“…BACKGROUND To evaluate whether progress continues in identifying more effective treatments for children and adolescents with cancer, the authors examined both…”
Get full text

American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care by MCCABE, Mary S, BHATIA, Smita, OEFFINGER, Kevin C, REAMAN, Gregory H, TYNE, Courtney, WOLLINS, Dana S, HUDSON, Melissa M

Get full text

Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century by SMITH, Malcolm A, SEIBEL, Nita L, ALTEKRUSE, Sean F, RIES, Lynn A. G, MELBERT, Danielle L, O'LEARY, Maura, SMITH, Franklin O, REAMAN, Gregory H

“…This report provides an overview of current childhood cancer statistics to facilitate analysis of the impact of past research discoveries on outcome and…”
Get full text

Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries by Pritchard-Jones, Kathy, Prof, Pieters, Rob, Prof, Reaman, Gregory H, Prof, Hjorth, Lars, PhD, Downie, Peter, MD, Calaminus, Gabriele, MD, Naafs-Wilstra, Marianne C, MA, Steliarova-Foucher, Eva, PhD

“…Summary Cancer in children and adolescents is rare and biologically very different from cancer in adults. It accounts for 1·4% of all cancers worldwide,…”
Get full text

JAK mutations in high-risk childhood acute lymphoblastic leukemia by Mullighan, Charles G, Zhang, Jinghui, Harvey, Richard C, Collins-Underwood, J. Racquel, Schulman, Brenda A, Phillips, Letha A, Tasian, Sarah K, Loh, Mignon L, Su, Xiaoping, Liu, Wei, Devidas, Meenakshi, Atlas, Susan R, Chen, I. Ming, Clifford, Robert J, Gerhard, Daniela S, Carroll, William L, Reaman, Gregory H, Smith, Malcolm, Downing, James R, Hunger, Stephen P, Willman, Cheryl L

“…Pediatric acute lymphoblastic leukemia (ALL) is a heterogeneous disease consisting of distinct clinical and biological subtypes that are characterized by…”
Get full text

ARID5B Genetic Polymorphisms Contribute to Racial Disparities in the Incidence and Treatment Outcome of Childhood Acute Lymphoblastic Leukemia by HENG XU, CHENG CHENG, ENG, Celeste, DEAN, Michael, ANTILLON, Frederico, WINICK, Naomi J, MARTIN, Paul L, WILLMAN, Cheryl L, CAMITTA, Bruce M, REAMAN, Gregory H, CARROLL, William L, LOH, Mignon, DEVIDAS, Meenakshi, EVANS, William E, PUI, Ching-Hon, HUNGER, Stephen P, RELLING, Mary V, YANG, Jun J, DEQING PEI, YIPING FAN, WENJIAN YANG, NEALE, Geoff, SCHEET, Paul, BURCHARD, Esteban G, TORGERSON, Dara G

“…Recent genome-wide screens have identified genetic variations in ARID5B associated with susceptibility to childhood acute lymphoblastic leukemia (ALL). We…”
Get full text

Remaining Challenges in Childhood Cancer and Newer Targeted Therapeutics by Smith, Malcolm A., MD, PhD, Reaman, Gregory H., MD

“…Despite the enormously important and gratifying advances in cancer treatment outcomes for children with cancer, cancer remains the biggest cause of death from…”
Get full text

KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study by Robinson, Blaine W, Kairalla, John A, Devidas, Meenakshi, Carroll, Andrew J, Harvey, Richard C, Heerema, Nyla A, Willman, Cheryl L, Ball, Amanda R, Woods, Elliot C, Ballantyne, Nancy C, Urtishak, Karen A, Behm, Frederick G, Reaman, Gregory H, Hilden, Joanne M, Camitta, Bruce M, Winick, Naomi J, Pullen, Jeanette, Carroll, William L, Hunger, Stephen P, Dreyer, ZoAnn E, Felix, Carolyn A

Get full text

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia by Kang, Huining, Chen, I.-Ming, Wilson, Carla S., Bedrick, Edward J., Harvey, Richard C., Atlas, Susan R., Devidas, Meenakshi, Mullighan, Charles G., Wang, Xuefei, Murphy, Maurice, Ar, Kerem, Wharton, Walker, Borowitz, Michael J., Bowman, W. Paul, Bhojwani, Deepa, Carroll, William L., Camitta, Bruce M., Reaman, Gregory H., Smith, Malcolm A., Downing, James R., Hunger, Stephen P., Willman, Cheryl L.

“…To determine whether gene expression profiling could improve outcome prediction in children with acute lymphoblastic leukemia (ALL) at high risk for relapse,…”
Get full text

Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study by Kang, Huining, Wilson, Carla S., Harvey, Richard C., Chen, I.-Ming, Murphy, Maurice H., Atlas, Susan R., Bedrick, Edward J., Devidas, Meenakshi, Carroll, Andrew J., Robinson, Blaine W., Stam, Ronald W., Valsecchi, Maria G., Pieters, Rob, Heerema, Nyla A., Hilden, Joanne M., Felix, Carolyn A., Reaman, Gregory H., Camitta, Bruce, Winick, Naomi, Carroll, William L., Dreyer, ZoAnn E., Hunger, Stephen P., Willman, Cheryl L.

“…Gene expression profiling was performed on 97 cases of infant ALL from Children's Oncology Group Trial P9407. Statistical modeling of an outcome predictor…”
Get full text

Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue: A Report From the Children's Oncology Group by Gilman, Andrew L, Ozkaynak, M Fevzi, Matthay, Katherine K, Krailo, Mark, Yu, Alice L, Gan, Jacek, Sternberg, Adam, Hank, Jacquelyn A, Seeger, Robert, Reaman, Gregory H, Sondel, Paul M

“…Recurrence of high-risk neuroblastoma is common despite multimodality therapy. ch14.18, a chimeric human/murine anti-G(D2) antibody, lyses neuroblastoma cells…”
Get full text

Phase I Trial of Oral Fenretinide in Children With High-Risk Solid Tumors: A Report From the Children's Oncology Group (CCG 09709) by VILLABLANCA, Judith G, KRAILO, Mark D, AMES, Matthew M, REID, Joel M, REAMAN, Gregory H, REYNOLDS, Patrick C

“…To determine the maximal tolerated dosage (MTD) of oral fenretinide given as intact capsules for 7 days, repeated every 21 days, in children with high-risk…”
Get full text

Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3) by Dreyer, ZoAnn E., Hilden, Joanne M., Jones, Tamekia L., Devidas, Meenakshi, Winick, Naomi J., Willman, Cheryl L., Harvey, Richard C., Chen, I-Ming, Behm, Fred G., Pullen, Jeanette, Wood, Brent L., Carroll, Andrew J., Heerema, Nyla A., Felix, Carolyn A., Robinson, Blaine, Reaman, Gregory H., Salzer, Wanda L., Hunger, Stephen P., Carroll, William L., Camitta, Bruce M.

“…Background Infants with acute lymphoblastic leukemia (ALL) present with aggressive disease and a poor prognosis. Early relapse within 6–9 months of diagnosis…”
Get full text

Analysis of the Role of Hematopoietic Stem-Cell Transplantation in Infants With Acute Lymphoblastic Leukemia in First Remission and MLL Gene Rearrangements: A Report From the Children's Oncology Group by DREYER, Zoann E, DINNDORF, Patricia A, WILLMAN, Cheryl L, CARROLL, Andrew J, BEHM, Fred, SMITH, Franklin O, WOODS, William G, GODDER, Kamar, REAMAN, Gregory H, CAMITTA, Bruce, SATHER, Harland, LA, Mei K, DEVIDAS, Meenakshi, HILDEN, Joanne M, HEEREMA, Nyla A, SANDERS, Jean E, MCGLENNEN, Ron

“…Although the majority of children with acute lymphoblastic leukemia (ALL) are cured with current therapy, the event-free survival (EFS) of infants with ALL,…”
Get full text

Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia by Urtishak, Karen A., Edwards, Alena Y.Z., Wang, Li-San, Hudome, Amanda, Robinson, Blaine W., Barrett, Jeffrey S., Cao, Kajia, Cory, Lori, Moore, Jonni S., Bantly, Andrew D., Yu, Qian-Chun, Chen, I-Ming L., Atlas, Susan R., Willman, Cheryl L., Kundu, Mondira, Carroll, Andrew J., Heerema, Nyla A., Devidas, Meenakshi, Hilden, Joanne M., Dreyer, ZoAnn E., Hunger, Stephen P., Reaman, Gregory H., Felix, Carolyn A.

“…Survival in infants younger than 1 year who have acute lymphoblastic leukemia (ALL) is inferior whether MLL is rearranged (R) or germline (G). MLL…”
Get full text

Maternal Diet and Infant Leukemia: The DNA Topoisomerase II Inhibitor Hypothesis: A Report from the Children's Oncology Group by SPECTOR, Logan G, YANG XIE, BLAIR, Cindy K, REAMAN, Gregory H, ROSS, Julie A, ROBISON, Leslie L, HEEREMA, Nyla A, HILDEN, Joanne M, LANGE, Beverly, FELIX, Carolyn A, DAVIES, Stella M, SLAVIN, Joanne, POTTER, John D

“…Background: The MLL 11q23 translocation arises in utero and is present in 75% of infant leukemias. That MLL+ acute myeloid leukemia (AML) can arise following…”
Get full text

Recombinant Urate Oxidase for the Prophylaxis or Treatment of Hyperuricemia in Patients With Leukemia or Lymphoma by PUI, Ching-Hon, MAHMOUD, Hazem H, WILEY, Joseph M, WOODS, Gerald M, LEVERGER, Guy, CAMITTA, Bruce, HASTINGS, Caroline, BLANEY, Susan M, RELLING, Mary V, REAMAN, Gregory H

“…To improve the control of hyperuricemia in patients with leukemia or lymphoma, we tested a newly developed uricolytic agent, recombinant urate oxidase…”
Get full text

Fine‐Tuning the Relevance of Molecular Targets to Pediatric Cancer: Addressing Additional Layers of Complexity by Charlab, Rosane, Burckart, Gilbert J., Reaman, Gregory H.

“…The Research to Accelerate Cures and Equity (RACE) for Children Act requires an assessment of molecular targets relevant to pediatric cancer. Due to the…”
Get full text

Clinical Cancer Advances 2006: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology by OZOIS, Robert F, HERBST, Roy S, MARKMAN, Maurie, MAYER, Robert J, RAGHAVAN, Derek, REAMAN, Gregory H, SAWAYA, Raymond, SCHIKKY, Richard L, SCHUCHTER, Lynn M, SWEETENHAM, John W, VAHDAT, Linda T, WINN, Rodger J, COLSON, Yolonda L, GRALOW, Julie, BONNER, James, CURRANT, Walter J, EISENBERG, Burton L, GANZ, Patricia A, KRAMER, Barnett S, KRIS, Mark G

“…A MESSAGE FROM ASCO's PRESIDENT For the second consecutive year, the American Society of Clinical Oncology (ASCO) is publishing Clinical Cancer Advances: Major…”
Get full text